Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00525629 · ClinicalTrials.gov registry record · NA
The Metabolic Effects of Short-term Walnut Consumption in Subjects With the Metabolic Syndrome
A NA study of Type 2 Diabetes and Cardiovascular Disease, sponsored by Christos Mantzoros.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT00525629 is a NA study of Type 2 Diabetes and Cardiovascular Disease that has completed, run by Christos Mantzoros. The registered enrollment target is 40 participants, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00525629, a NA study of Type 2 Diabetes and Cardiovascular Disease, has completed, sponsored by Christos Mantzoros.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Walnuts include many potentially beneficial micronutrients and phytochemicals, in this study we propose to examine the effects of walnuts independent of macronutrient content. The purpose of this proposal is to study in depth the short-term effects of walnut consumption in men and women with the metabolic syndrome. Study Aim 1: To investigate the effects of walnuts (48gms per day over 3 days) on insulin resistance in subjects with the metabolic syndrome. Study Aim 2: To investigate the effects of 48gms per day of walnuts over 3 days on lipids and inflammatory markers. Study Aim 3: To assess the possible mechanisms of the biological effects of short-term walnut consumption through assessment of adipokines, resting metabolic rate, gene expression in white blood cells and the effect of walnuts when consumed as part of a mixed meal, on glucose excursions, insulin secretion and the excretion of gut peptides and free fatty acids.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Walnuts
- DIETARY_SUPPLEMENT Control
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-02 |
| Est. Completion | 2008-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00525629
The ClinicalTrials.gov registry entry for NCT00525629 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,102-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is Christos Mantzoros, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Walnuts is the first listed.
NCT00525629 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00525629 about?
NCT00525629 is a clinical study titled "The Metabolic Effects of Short-term Walnut Consumption in Subjects With the Metabolic Syndrome". Walnuts include many potentially beneficial micronutrients and phytochemicals, in this study we propose to examine the effects of walnuts independent of macronutrient content. The purpose of this proposal is to study in depth the short-term effects of walnut consumption in men and women with the met...
What is the current status of trial NCT00525629?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2007-02. Estimated completion is 2008-12.
What conditions does trial NCT00525629 study?
This clinical trial studies the following conditions: Type 2 Diabetes, Cardiovascular Disease, Metabolic Syndrome.
What interventions are being tested in trial NCT00525629?
The interventions under investigation include: Walnuts (DIETARY_SUPPLEMENT), Control (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00525629?
This trial is sponsored by Christos Mantzoros, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00525629 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.